NeuroBionics

10x less invasive brain-computer interfaces

Human 3 criteria:

Prior evidence of human use

Step change

NeuroBionics is leveraging breakthroughs in materials science to make deep brain stimulation (DBS) 10x less invasive. Traditional DBS is highly effective for diseases like Parkinson’s, but requires open brain surgery, which deters nearly 98% of eligible patients. Neurobionics’ fibers are thin enough to be inserted endovascularly via catheter in an outpatient procedure.

Under the radar for now - more info soon.

2024

XEIA invests

2025

$3M raise led by Dolby Family Ventures

$3M raise led by Dolby Family Ventures

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC